Diffuse Alveolar Hemorrhage clinical trials at UCSF

1 research study open to eligible people

Diffuse alveolar hemorrhage means bleeding in the small lung air sacs. UCSF is researching lung complications in kids who received stem cell transplants. This study focuses on how these treatments impact lung health over time.

Showing trials for

  • TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

    open to eligible people ages up to 24 years

    Hematopoietic stem cell transplant (HSCT) is an effective but toxic therapy and pulmonary morbidity affects as many as 25% of children receiving transplant. Early pulmonary injury includes diffuse alveolar hemorrhage (DAH), thrombotic…

    San Francisco, California and other locations

Last updated: